Learn why leucovorin may be more effective for those with folate receptor autoantibodies and how it helps bypass blocked folate pathways.
Discover why early FRAT® testing is vital for your child’s brain development and how timely detection of FRAAs can prevent lifelong neurological challenges.
Discover how folate receptor autoantibodies contribute to cerebral folate deficiency and a distinct autism subgroup, including prevalence, mechanisms, and treatment.
Learn how soluble folate-binding proteins impact folate metabolism in autism and why leucovorin shows promise for improving core ASD symptoms.
Learn why folate is vital for early brain development—boosting neurogenesis, myelination, and cognitive outcomes from pregnancy to early childhood.
FRAT® detects blocking and binding folate receptor autoantibodies linked to Cerebral Folate Deficiency and autism, guiding targeted folinic acid therapy.
Discover how the FRAT® test identifies autism patients who may benefit from leucovorin therapy, enabling precision treatment for cerebral folate deficiency.
Understand how Leucovorin and 5-MTHF differ in treating Folate Receptor Autoantibodies and why Leucovorin may work better in Cerebral Folate Deficiency.
Discover why some autistic children seem overly friendly and how gentle guidance can help them build safe, confident social connections.
Discover why screening for folate receptor autoantibodies (FRAAs) is vital in diagnosing and treating neurological and neurodevelopmental disorders effectively.